Showing 381 - 400 results of 233,050 for search '(( 10 ((mg decrease) OR (we decrease)) ) OR ( 10 ((mean decrease) OR (a decrease)) ))', query time: 1.63s Refine Results
  1. 381
  2. 382

    GSH, but not GSSG, specifically decreases ABCB10 ATP binding activity. by Wei Qiu (217045)

    Published 2015
    “…<p>A representative autoradiography image and the quantification shown in the bar graph demonstrate that GSH decreased [α-<sup>32</sup>P] 8-azido-ATP signal in ABCB10 from SMPs in a dose dependent manner, whereas GSSG did not. …”
  3. 383
  4. 384
  5. 385
  6. 386
  7. 387

    <i>USP28</i> protein level was decreased by hypoxia signaling via both protein degradation and transcriptional repression in A549 cells. by Qin Li (36669)

    Published 2013
    “…<p>(A) A549 cells were transfected with non-coding control siRNA or siRNA targeting human <i>HIF-1α</i> and <i>HIF-2α</i> (<i>HIF-1α</i> RNAi and <i>HIF-2α</i> RNAi mixture) for 48 hr, and then were treated with 1.0 mM NiSO<sub>4</sub> or cultured in 1% O<sub>2</sub> (Hy) for another 24 hr. …”
  8. 388
  9. 389
  10. 390

    Anti-TGFβ antibody treatment decreases tumor burden in tumor-bearing mice. by Swati Biswas (73661)

    Published 2013
    “…White line indicates the presence of tumor. <b>Panel b:</b> A boxplot of tumor burden in MDA-MB-231 tumor-bearing mice treated with either 13C4 (10 mg/kg) or 1D11(10 mg/kg) for 4 weeks, starting 1 day after tumor cell injection (N = at least 7) showing decrease in tumor burden. …”
  11. 391
  12. 392
  13. 393
  14. 394
  15. 395
  16. 396
  17. 397

    LPS decreases cardiac expression of miR-29c for 3–7 days. by Wilbur Y. W. Lew (400836)

    Published 2014
    “…(n = 3), or 7 days after LPS (10 mg/kg i.p.) (n = 3). There was a significant decrease in miR-29c with LPS (P = 0.02, one way ANOVA). …”
  18. 398
  19. 399

    <i>Trans ε</i> viniferin decreases amyloid deposits and inflammation in a mouse transgenic Alzheimer model by Martial Caillaud (6383672)

    Published 2019
    “…Here, effects of this stilbenoid were evaluated in transgenic APPswePS1dE9 mice. We report that <i>trans ε</i>-viniferin could go through the blood brain barrier, reduces size and density of amyloid deposits and decreases reactivity of astrocytes and microglia, after a weekly intraperitoneal injection at 10 mg/kg from 3 to 6 months of age.…”
  20. 400